genetic-diversity
(2)
Meiogenix
Meiogenix is a French-American agricultural biotech company that re-engineers one of nature's oldest tricks - meiotic recombination, the gene-shuffling that happens when plants make seeds. Instead of editing single genes like CRISPR, its proprietary SpiX and dCas9-SPO11 platforms steer where chromosomes cross over, unlocking 'cold' regions of the genome that conventional breeding can never reach. The result: breeders can mix desirable traits, break unwanted linkage, and shrink crop development cycles from 10-plus years to as few as three, all without introducing foreign DNA. Founded in 2010 as a spin-off from Institut Curie and INRA, the company targets the $50B+ commercial seed market across corn, wheat, rice, tomato and soybean, and licenses its technology to partners including Bayer.
Ricardo Alba
Ricardo Garcia de Alba is the President and CEO of Meiogenix, an agriculture biotech company whose chromosome-editing platform speeds up the way crops naturally reshuffle their own DNA. A chemical engineer from Mexico City turned global ag executive, he spent 15 years at Corteva Agriscience helping build and launch the Enlist weed-control system before taking the helm at Meiogenix in 2024. He pairs hard science and commercial scale with a long habit of community and STEM service - and keeps bees on the side.